| 000 | 01648nam a2200361 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223025924.0 | ||
| 008 | 090909s2009 ua d f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.01.M.Sc.2009.Re.C | ||
| 100 | 0 | _aReda Mahmoud Mohamed | |
| 245 | 1 | 0 |
_aCalcium sensitizing agents in the failing heart / _cReda Mahmoud Mohamed ; Supervised Hoda Abdelkader Ghanem , Mohamed Abdelhamid , Hesham Hosni Abdelwahab |
| 246 | 1 | 5 | _aالادوية المحفزة للكالسيوم فى حالات فشل القلب |
| 260 |
_aCairo : _bReda Mahmoud Mohamed , _c2009 |
||
| 300 |
_a82 P. : _bcharts ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Anaesthesia | ||
| 520 | _aFor acute worsening of heart failure, the short-term administration of levosimendan, a new inotrope with calcium sensitizing properties, appears to be safer than dobutamine. Also, in acute heart failure after myocardial infarction, levosimendan improved symptoms and halved mortality during the first 72h, a difference in mortality which was maintained over the nex16 months | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aCalcium sensitizers | |
| 653 | 4 | _aHeart failure | |
| 653 | 4 | _aLevosimendan | |
| 700 | 0 |
_aHesham Hosni Abdelwahab , _eSupervisor |
|
| 700 | 0 |
_aHoda Abdelkader Ghanem , _eSupervisor |
|
| 700 | 0 |
_aMohamed Abdelhamid , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 902 | _a1 | ||
| 905 |
_aMustafa _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c23599 _d23599 |
||